President Joe Biden, speaking at the White House on Sunday some 12 hours after signing stopgap legislation to avert a federal government shutdown, called on House Speaker Kevin McCarthy and fellow Republicans to maintain the U.S.’s commitment to assist Ukraine in its ongoing defense against the Russian invasion that began in February 2022. McCarthy, the president said, has committed to bring a Ukraine assistance bill to the House floor, after McCarthy, who has to varying degrees publicly expressed support for the Ukraine cause, removed Ukraine funds from the 45-day continuing resolution passed Saturday, with Democratic backing, to assuage his own intraparty detractors. “Let’s be clear,” said Biden. “I hope my friends on the other side [of the aisle] keep their word about support for Ukraine. They said they’re going to support Ukraine in a separate vote.” Biden called the government-shutdown near-miss “a manufactured crisis” brought about when Republicans walked away from the compromises reached in May, when McCarthy and Biden came together to resolve a debt-ceiling impasse. “I’m sick and tired of the brinksmanship.”

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

A Lockheed Martin Corp. LMT subsidiary on Friday landed a $1.2 billion U.S. Navy contract modification for Trident II missile production and deployment systems support. Lockheed Martin Space’s project is expected to be completed by Sept. 30, 2028. Shares of Lockheed Martin are flat in after-hours trading.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

SmileDirectClub Inc. SDC said late Friday it is voluntarily filing for Chapter 11 bankruptcy protection as founders are investing to recapitalize the teeth-straightening company. SmileDirectClub shares were halted at an 0.8% gain in the extended session Friday, having closed the regular session down 6.6% at 87 cents a share. The company said its “founders have committed to invest at least $20 million to bolster the company’s balance sheet and to protect its near- and long-term financial health,” and that “up to $60 million of additional capital is available upon satisfaction of certain conditions.” The company filed for Chapter 11 bankruptcy protection in the southern district of Texas.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Intel Corp. INTC shares rose for a fourth consecutive quarter Friday, giving the chip maker its longest quarterly winning streak in 13-and-a-half years. Intel shares rose 1.1% Friday to close at $35.55, for the stock’s fourth straight quarter of gains, its longest quarterly winning streak since the five-quarter streak ending with the first quarter of 2010, according to Dow Jones Market Data. Over the past 12 months, Intel shares have gained 34.8%, while the PHLX Semiconductor Index SOX has advanced 46.3%, the S&P 500 index SPX has gained 17.8%, and the tech-heavy Nasdaq Composite COMP has risen 23.1%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Biogen Inc. BIIB said late Friday the Food and Drug Administration approved its biosimilar version of Roche CH:ROG‘s arthritis treatment Actemra. Biogen said its treatment Tofidence, or tocilizumab-bavi, is the first FDA-approved biosimilar to tocilizumab, which Roche brands as Actemra. Biogen’s approval covers marketing for the treatment of moderately to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and systemic juvenile idiopathic arthritis, the company said. Biosimilars are to branded biologics the way generic drugs are to branded drugs except the FDA regulates the two classes in different ways.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.